Jon Erik Brænden
Vice President Production at Kappa Bioscience AS- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
-
English Professional working proficiency
Topline Score
Bio
Experience
-
Kappa Bioscience, a Balchem company
-
Norway
-
Biotechnology Research
-
1 - 100 Employee
-
Vice President Production
-
Nov 2018 - Present
Kappa Bioscience is a Norwegian based entity founded in 2006 manufacturing high purity synthetic vitamin K2 as menaquinone-7 (MK-7). We have extensive knowledge about vitamins and supply various formulations of vitamin K2 for nutritional supplementation and food. Kappa Bioscience has around 50 employees of which approximately 50% are based in Hamburg, Germany. The German site cover sales, marketing and distribution. Via Hamburg we also provide other ingredients such as vitamin D3, calcium and magnesium.VP Production major responsibility areas:- Overall responsibility for the company's production and delivery of products, including primary and secondary production- Personnel responsibility for production department- Deliver products according to specification, plan, cost, time and quality- Implement process improvements developed by R & D- Implement quality standards according to the company's goals and strategy- Budget responsibility for the company's production activity- Food Safety Group Member Show less
-
-
Head Of Production
-
Oct 2018 - Nov 2018
-
-
-
Vistin Pharma AS
-
Norway
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Process Development Specialist
-
Jun 2015 - Sep 2018
Vistin Pharma is a Norwegian pharmaceutical company producing Active Pharmaceutical Ingredients (APIs) and solid dosage forms for the global pharmaceutical industry. The Group was established in 2015 when Vistin Pharma AS acquired the metformin and opioids business and tablet production assets from Weifa AS. On 2 October 2017, Vistin Pharma sold its opioids and CMO business to TPI Enterprises Limited. Following the sale, Vistin Pharma is a pure play metformin producer, with a strong position in the global metformin market and with significant growth ambitions. Metformin is used as the first line treatment of diabetes 2, a disease which is expected to grow by 50 per cent towards 2030, and affect more than 500 million people. My responsibilities remains the same as in Weifa AS, however since October 2017, no longer within the opioid business. Show less
-
-
-
Weifa AS
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Process Development Specialist
-
Aug 2013 - May 2015
Responsibility for development of manufacturing processes for active pharmaceutical ingredients (APIs). Optimization of processes, capacity increase and cost reduction. Planning and performing laboratory and pilot scale experiments in collaboration with contract research organizations, and implementation of new procedures in production scale. Preparation of regulatory documentation according to authority requirements (GMP, ICH guidelines, etc.), including answering requests from authorities and customers. Evaluation of new APIs, raw materials and suppliers, as well as taking part in inspections when required. Show less
-
-
-
Photocure
-
Norway
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Chemical Development Director
-
Jun 1999 - Jul 2013
Responsibility for manufacture, control and documentation of active pharmaceutical ingredients (APIs) for use in commercial medicinal products, as well as for pre-clinical and clinical testing Responsibility for technology transfer and scale up between different manufacturers or internally at manufacturers Choice of manufacturing partners and contract research organizations, including preparation of quality and manufacturing agreements Preparation of regulatory documentation according to authority requirements (GMP, ICH guidelines, FDA etc.), in collaboration with partners for start of pre-clinical and clinical testing, as well as for marketing authorization applications Responsibility for budget, project progress, production regularity and success rate for active pharmaceutical ingredients Auditing and inspections of manufacturing partners Responsibility for research, synthesis and characterization of new chemical entities (NCEs) for pre-clinical testing and for use as examples in patents Show less
-
-
-
Takeda Pharmaceuticals (formerly Nycomed)
-
Switzerland
-
Pharmaceutical Manufacturing
-
500 - 600 Employee
-
Senior Research Scientist
-
1993 - 1999
Process Chemistry Department Research Scientist 1993-1997 Senior Research Scientist 1997-1999 Planning and performing multistep organic syntheses of APIs, including scale up (up to 10 liters) and some polymer chemistry Process development and optimization, including experimental design and multivariate analyses Process Chemistry Department Research Scientist 1993-1997 Senior Research Scientist 1997-1999 Planning and performing multistep organic syntheses of APIs, including scale up (up to 10 liters) and some polymer chemistry Process development and optimization, including experimental design and multivariate analyses
-
-
-
Chiron Laboratories AS
-
Trondheim, Norway
-
Project manager
-
1992 - 1993
Project management Fine Chemistry Department Development of synthetic route and preparation of optical pure organic compounds for use as fine chemicals or starting materials for pharmaceuticals Manufacture and scale up of processes in both internal and external facilities (pilot plant) Project management Fine Chemistry Department Development of synthetic route and preparation of optical pure organic compounds for use as fine chemicals or starting materials for pharmaceuticals Manufacture and scale up of processes in both internal and external facilities (pilot plant)
-
-
Education
-
Norges Tekniske Høgskole (NTH)
Dr. ing., Organic chemistry -
Norges Tekniske Høgskole (NTH)
Siv. ing., Organic Chemistry